Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.
Bill would rein in “pharmacy benefit managers,” or PBMs, which have come under fire for driving up prescription drug costs ...
One initiative that has been scrapped would have offered some generic drugs to Medicare enrollees for $2. Meanwhile, the Trump administration has backed off hospice oversight.
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Cigna’s CFO, Brian Evanko, addressed financial and operational updates at the Barclays Healthcare Conference. The company ...
The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...
On Tuesday in Hartford, a task force of legislators presented a series of recommendations to bring down the cost of ...
The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by ...
Tampa Free Press on MSN6d
Lawmakers Unveil Bipartisan Bill To Rein In Pharmacy Benefit Managers, Slash Drug Costs For SeniorsMaggie Hassan (D-NH), and Mark Warner (D-VA)—introduced the Patients Before Middlemen (PBM) Act on Thursday, targeting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback